DOI QR코드

DOI QR Code

Relationship between the Serum De Ritis Ratio and Diabetes Tests in Korean Adults Who Underwent Health Screening at a General Hospital in Gyeonggi-do

경기도 일개 종합병원에서 건강검진을 받은 한국 성인의 혈청 De Ritis 비율과 당뇨 검사와의 관계

  • Hyun Ho SUNG (Department of Clinical Laboratory Science, Dongnam Health University) ;
  • Ho-Keun CHOI (Department of Laboratory Medicine, Hallym University Sacred Heart Hospital)
  • 성현호 (동남보건대학교 임상병리과) ;
  • 최호근 (한림대학교성심병원 진단검사의학과)
  • Received : 2023.02.20
  • Accepted : 2023.03.09
  • Published : 2023.03.31

Abstract

The purpose of this study was to analyze the relationship between diabetes and liver function test results. Unlike type 2 diabetes mellitus (T2DM), hepatogenous diabetes is caused by abnormal liver function. In this study, the relationship between liver enzymes, aspartate aminotransferase (AST), alanine transaminase (ALT), and the AST/ALT ratio (De Ritis ratio), indicating liver function, and diabetes-related tests was analyzed. The results of the study showed a positive correlation between AST and glucose (r=0.14, P<0.01), ALT and glucose (r=0.21, P<0.01), AST and glycated hemoglobin (HbA1c) (r=0.15, P<0.01), and ALT and HbA1c (r=0.20, P<0.01). The De Ritis ratio showed a negative correlation with glucose (r=-0.20, P<0.01) and HbA1c (r=-0.14, P<0.01). The results of regression analysis with AST, ALT, and the De Ritis ratio as independent variables and glucose (R2=0.05) and HbA1c (R2=0.04) as dependent variables revealed that the independent variables had a statistically significant effect on the dependent variables. AST showed a lower correlation between blood glucose and glycated hemoglobin than ALT, and an increase in ALT caused a decrease in the De Ritis ratio. Therefore, the De Ritis ratio can be said to be meaningful in relation to diabetes-related tests.

본 연구의 목적은 당뇨 검사결과와 간기능검사와의 관계연구이다. 간성당뇨는 제2형 당뇨와는 다르게 간기능 이상으로 기인하는 것이다. 본 연구에서 간기능 검사의 주요 효소검사인 아스파르트산 아미노전이효소(aspartate aminotransferase, AST), 알라닌 아미노전이효소(alanine aminotransferase, ALT) 그리고 AST/ALT ratio (De Ritis ratio)와 당뇨관련 검사와의 관계를 주로 확인하였다. 연구 결과 AST와 글루코스(glucose) (r=0.14, P<0.01); ALT 및 글루코스(r=0.21, P<0.01); AST 및 당화혈색소(HbAlc) (r=0.15, P<0.01); ALT와 HbAlc (r=0.20, P<0.01), 모든 변수는 양의 상관관계를 나타났으며, De Ritis ratio는 글루코스 (r=-0.20, P<0.01)와 당화혈색소 (r=-0.14, P<0.01)와 음의 상관관계를 보였다. AST와 ALT 그리고 De Ritis ratio 를 독립변수로 하고 글루코스 (R2=0.05) 와 HbA1c (R2=0.04) 를 종속변수로 하여 회귀분석한 결과 독립변수는 종속변수에 통계적으로 유의하게 영향을 나타내는 것으로 나타났다. AST는 ALT 보다 혈당과 당화혈색소에서 상관관계가 낮게 나타났으며, ALT가 증가하는 것은 즉, De Ritis ratio 감소의 원인이 된다. 따라서, De Ritis ratio는 당뇨관련 검사와의 관계에서 의미가 있는 것으로 볼 수 있다.

Keywords

Acknowledgement

This study was financially supported by Dongnam Health University.

References

  1. Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr. 2015;4:101-108. https://doi.org/10.3978/j.issn.2304-3881.2015.01.03
  2. Blendea MC, Thompson MJ, Malkani S. Diabetes and chronic liver disease: etiology and pitfalls in monitoring. Clin Diabetes. 2010;28:139-144. https://doi.org/10.2337/diaclin.28.4.139
  3. Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study. BMJ Open Diabetes Res Care. 2020;8:e001629. https://doi.org/10.1136/bmjdrc-2020-001629
  4. Leite NC, Villela-Nogueira CA, Cardoso CR, Salles GF. Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. World J Gastroenterol. 2014;20: 8377-8392. https://doi.org/10.3748/wjg.v20.i26.8377
  5. Lee SJ, Lee BW. Diabetes mellitus and non-alcoholic fatty liver disease: diagnosis and treatment. J Korean Diabetes. 2021;22:38-45. https://doi.org/10.4093/jkd.2021.22.1.38
  6. Niu H, Zhou Y. Nonlinear relationship between AST-to-ALT ratio and the incidence of type 2 diabetes mellitus: a follow-up study. Int J Gen Med. 2021;14:8373-8382. https://doi.org/10.2147/IJGM.S341790
  7. Botros M, Sikaris KA. The de ritis ratio: the test of time. Clin Biochem Rev. 2013;34:117-130.
  8. Lala V, Zubair M, Minter DA. Liver function tests [Internet]. Treasure Island: StatPearls Publishing [cited 2022 November 15]. Available from: https://europepmc.org/article/med/29494096
  9. Kumar R. Hepatogenous diabetes: an underestimated problem of liver cirrhosis. Indian J Endocrinol Metab. 2018;22:552-559. https://doi.org/10.4103/ijem.IJEM_79_18
  10. Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet. 1967;2:1051-1056. https://doi.org/10.1016/s0140-6736(67)90334-0
  11. Orsi E, Grancini V, Menini S, Aghemo A, Pugliese G. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? Liver Int. 2017;37:950-962. https://doi.org/10.1111/liv.13337
  12. McClatchey KD. Clinical laboratory medicine. 2nd ed. Philadelphia: Williams & Wilkins; 2002. p288-290.
  13. Chen L, Zhang K, Li X, Wu Y, Liu Q, Xu L, et al. Association between aspartate aminotransferase to alanine aminotransferase ratio and incidence of type 2 diabetes mellitus in the Japanese population: a secondary analysis of a retrospective cohort study. Diabetes Metab Syndr Obes. 2021;14:4483-4495. https://doi.org/10.2147/DMSO.S337416
  14. Chen W, Wang W, Zhou L, Zhou J, He L, Li J, et al. Elevated AST/ALT ratio is associated with all-cause mortality and cancer incident. J Clin Lab Anal. 2022;36:e24356. https://doi.org/10.1002/jcla.24356
  15. Christman AL, Lazo M, Clark JM, Selvin E. Low glycated hemoglobin and liver disease in the U.S. population. Diabetes Care. 2011;34:2548-2550. https://doi.org/10.2337/dc11-0944
  16. Al-Jameil N, Khan FA, Arjumand S, Khan MF, Tabassum H. Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients. Int J Clin Exp Pathol. 2014;7:4345-4349.
  17. Stefan N, Haring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7:313-324. https://doi.org/10.1016/S2213-8587(18)30154-2
  18. Yadav R, Bhartiya JP, Verma SK, Nandkeoliar MK. The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions. J Clin Diagn Res. 2013;7:1291-1294. https://doi.org/10.7860/JCDR/2013/6016.3120